STOCK TITAN

Conference call interim report

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conference call
Rhea-AI Summary

Vitrolife Group will host a conference call on July 17, 2024, at 10:00 a.m. CET to discuss its Q2 2024 interim report. Participants include CEO Bronwyn Brophy O'Connor and CFO Patrik Tolf. The interim report will be released at 8:00 a.m. CET on the same day, with presentation materials available on the company's website beforehand. Registration for the call is required, and a recorded version will be accessible via an international phone number for seven days. This announcement was made on July 3, 2024, from Gothenburg, Sweden.

Positive
  • Vitrolife Group is engaging with stakeholders through a detailed conference call.
  • The interim report provides transparency, helping investors make informed decisions.
Negative
  • None.

GOTHENBURG, Sweden, July 3, 2024 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2024. The presentation will be held in English.

Time: Wednesday 17 July, 2024 at 10.00 a.m. CET.

To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group

Register for the call here

Vitrolife Group participants:
Bronwyn Brophy O´Connor, CEO
Patrik Tolf, CFO

The press release for the interim report will be released at 8.00 CET on the same day.

Before the conference call, presentation material will be available at the company web page.

A recorded version of the telephone conference will be available for seven days on number +44 (0) 20 3451 9993 (International), access code 7692641#.

Gothenburg, 3 July 2024
VITROLIFE AB (publ)

Contact: 
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/vitrolife-ab--publ-/r/conference-call-interim-report,c4010494

The following files are available for download:

https://mb.cision.com/Main/1031/4010494/2898756.pdf

Conference call interim report

 

Cision View original content:https://www.prnewswire.com/news-releases/conference-call-interim-report-302188898.html

SOURCE Vitrolife AB (publ)

FAQ

When is Vitrolife's Q2 2024 interim report being released?

Vitrolife's Q2 2024 interim report will be released on July 17, 2024, at 8:00 a.m. CET.

How can I attend the Vitrolife (VTRLY) conference call?

You can attend the Vitrolife (VTRLY) conference call by registering through the provided link. After registration, you will receive the necessary access details.

Who will be presenting at the Vitrolife (VTRLY) Q2 2024 conference call?

The presenters for the Vitrolife (VTRLY) Q2 2024 conference call will be CEO Bronwyn Brophy O'Connor and CFO Patrik Tolf.

What time is the Vitrolife (VTRLY) Q2 2024 conference call?

The Vitrolife (VTRLY) Q2 2024 conference call is scheduled for July 17, 2024, at 10:00 a.m. CET.

Where can I find the presentation materials for the Vitrolife (VTRLY) Q2 2024 interim report?

The presentation materials for the Vitrolife (VTRLY) Q2 2024 interim report will be available on the company's website before the conference call.

VITROLIFE AB UNSP/ADR

OTC:VTRLY

VTRLY Rankings

VTRLY Latest News

VTRLY Stock Data

3.39B
73.63M
Medical Devices
Healthcare
Link
United States of America
Gothenburg